TY - JOUR
T1 - Estimation of the effect of food on the disposition of oral 5-fluorouracil in combination with eniluracil
AU - Shepard, Dale R.
AU - Mani, Sridhar
AU - Kastrissios, Helen
AU - Learned-Coughlin, Susan
AU - Smith, Deborah
AU - Ertel, Phillip
AU - Magnum, Steve
AU - Janisch, Linda
AU - Fleming, Gini F.
AU - Schilsky, Richard L.
AU - Ratain, Mark J.
N1 - Funding Information:
This work was supported in part by a grant from Glaxo Wellcome and CA 14599.
PY - 2002
Y1 - 2002
N2 - Aims: To determine the effect of food on the pharmacokinetics of 5-fluoruracil (5-FU) taken orally with eniluracil and to compare the performance of different pharmacokinetic analysis methods in the detection a potential food-drug interaction. Methods: In a randomized, open-label, two-way crossover study, 12 patients received eniluracil (50 mg, orally) on days 1 and 2 and 5-FU (20 mg/m2, orally) on day 2 following either a 2-h fast or 20 min after a standard meal. Treatments were separated by 7 days. Timed blood samples were collected during the first two treatment periods and 5-FU concentrations determined by GC/MS. Data were analyzed and pharmacokinetic parameter estimates were obtained using a noncompartmental, two-stage and population analysis methods. Results: In fasted individuals, the clearance/bioavailability of 5-FU was estimated to be 5.6 l/h. The mean absorption lag-time was 0.24 h and was followed by rapid absorption of 5-FU. Administration of 5-FU and eniluracil with food resulted in a decrease in the 5-FU absorption rate constant by 90%. As a result, the peak plasma concentration (Cmax) of 5-FU was decreased by 21% and the time to Cmax was increased 2.9-fold. Clearance of 5-FU, relative bioavailability, and area under the plasma concentration vs time curve (AUC) remained unchanged with coad-ministration of food. Similar results were obtained using all three data analysis methods. Conclusions: Administration of food with oral 5-FU and eniluracil slowed absorption of 5-FU and decreased 5-FU Cmax, but did not e+ect AUC. Further investigation of the incorporation of population pharmacokinetic approaches in food e+ect studies is warranted.
AB - Aims: To determine the effect of food on the pharmacokinetics of 5-fluoruracil (5-FU) taken orally with eniluracil and to compare the performance of different pharmacokinetic analysis methods in the detection a potential food-drug interaction. Methods: In a randomized, open-label, two-way crossover study, 12 patients received eniluracil (50 mg, orally) on days 1 and 2 and 5-FU (20 mg/m2, orally) on day 2 following either a 2-h fast or 20 min after a standard meal. Treatments were separated by 7 days. Timed blood samples were collected during the first two treatment periods and 5-FU concentrations determined by GC/MS. Data were analyzed and pharmacokinetic parameter estimates were obtained using a noncompartmental, two-stage and population analysis methods. Results: In fasted individuals, the clearance/bioavailability of 5-FU was estimated to be 5.6 l/h. The mean absorption lag-time was 0.24 h and was followed by rapid absorption of 5-FU. Administration of 5-FU and eniluracil with food resulted in a decrease in the 5-FU absorption rate constant by 90%. As a result, the peak plasma concentration (Cmax) of 5-FU was decreased by 21% and the time to Cmax was increased 2.9-fold. Clearance of 5-FU, relative bioavailability, and area under the plasma concentration vs time curve (AUC) remained unchanged with coad-ministration of food. Similar results were obtained using all three data analysis methods. Conclusions: Administration of food with oral 5-FU and eniluracil slowed absorption of 5-FU and decreased 5-FU Cmax, but did not e+ect AUC. Further investigation of the incorporation of population pharmacokinetic approaches in food e+ect studies is warranted.
KW - 5-Fluorouracil
KW - Eniluracil
KW - Food-drug interaction
KW - Pharmacokinetic analysis
UR - http://www.scopus.com/inward/record.url?scp=0036232578&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036232578&partnerID=8YFLogxK
U2 - 10.1007/s00280-002-0431-9
DO - 10.1007/s00280-002-0431-9
M3 - Article
C2 - 11976834
AN - SCOPUS:0036232578
SN - 0344-5704
VL - 49
SP - 398
EP - 402
JO - Cancer Chemotherapy and Pharmacology
JF - Cancer Chemotherapy and Pharmacology
IS - 5
ER -